Tempus, a medical lab testing and data company started by a former co-founder of Groupon (GRPN), has hired Morgan Stanley (MS) to run an initial public offering in the coming months, The Information’s Becky Peterson and Cory Weinberg report, citing people familiar with the matter. The startup, which has raised more than $1.3B in private funding from investors such as Google (GOOGL), New Enterprise Associates and Baillie Gifford, would add to the backlog of venture-backed startups aiming to go public this year, the authors note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GRPN:
- Options Volatility and Implied Earnings Moves This Week, March 11 – March 15, 2024
- Groupon Settles Credit Debt Early, Secures New Financing
- Largest borrow rate increases among liquid names
- GRPN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Groupon price target raised to $7.50 from $5 at Goldman Sachs